153 related articles for article (PubMed ID: 29644477)
21. A pilot study of preoperative continuous infusion 5-fluorouracil, external microwave hyperthermia, and external beam radiotherapy for treatment of locally advanced, unresectable, or recurrent rectal cancer.
Anscher MS; Lee C; Hurwitz H; Tyler D; Prosnitz LR; Jowell P; Rosner G; Samulski T; Dewhirst MW
Int J Radiat Oncol Biol Phys; 2000 Jun; 47(3):719-24. PubMed ID: 10837956
[TBL] [Abstract][Full Text] [Related]
22. Randomized trial of short-course radiotherapy versus long-course chemoradiation comparing rates of local recurrence in patients with T3 rectal cancer: Trans-Tasman Radiation Oncology Group trial 01.04.
Ngan SY; Burmeister B; Fisher RJ; Solomon M; Goldstein D; Joseph D; Ackland SP; Schache D; McClure B; McLachlan SA; McKendrick J; Leong T; Hartopeanu C; Zalcberg J; Mackay J
J Clin Oncol; 2012 Nov; 30(31):3827-33. PubMed ID: 23008301
[TBL] [Abstract][Full Text] [Related]
23. Resectable rectal cancer: which patient does not need preoperative radiotherapy?
Kulu Y; Ulrich A; Büchler MW
Dig Dis; 2012; 30 Suppl 2():118-25. PubMed ID: 23207943
[TBL] [Abstract][Full Text] [Related]
24. Effect of increasing radiation dose on pathologic complete response in rectal cancer patients treated with neoadjuvant chemoradiation therapy.
Hall MD; Schultheiss TE; Smith DD; Fakih MG; Wong JY; Chen YJ
Acta Oncol; 2016 Dec; 55(12):1392-1399. PubMed ID: 27762654
[TBL] [Abstract][Full Text] [Related]
25. [Analysis of risk factors of distant metastasis in rectal cancer patients who received total mesorectal excision following neoadjuvant chemoradiotherapy].
Sun Y; Chi P; Lin H; Lu X; Huang Y; Xu Z; Huang S; Ye D; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Apr; 19(4):436-41. PubMed ID: 27112480
[TBL] [Abstract][Full Text] [Related]
26. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
[TBL] [Abstract][Full Text] [Related]
27. Lymph node micrometastasis in stage II distal rectal cancer following neoadjuvant chemoradiation therapy.
Perez RO; Habr-Gama A; Nishida Arazawa ST; Rawet V; Coelho Siqueira SA; Kiss DR; Gama-Rodrigues JJ
Int J Colorectal Dis; 2005 Sep; 20(5):434-9. PubMed ID: 15759124
[TBL] [Abstract][Full Text] [Related]
28. A Phase I trial of preoperative eniluracil plus 5-fluorouracil and radiation for locally advanced or unresectable adenocarcinoma of the rectum and colon.
Czito BG; Hong TJ; Cohen DP; Tyler DS; Lee CG; Anscher MS; Ludwig KA; Seigler HF; Mantyh C; Morse MA; Lockhart AC; Petros WP; Honeycutt W; Spector NL; Ertel PJ; Mangum SG; Hurwitz HI
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):779-85. PubMed ID: 14967434
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors for disease-free survival in patients with T3-4 or N+ rectal cancer treated with preoperative chemoradiation therapy, surgery, and intraoperative irradiation.
Díaz-González JA; Calvo FA; Cortés J; García-Sabrido JL; Gómez-Espí M; Del Valle E; Muñoz-Jiménez F; Alvarez E
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1122-8. PubMed ID: 16406393
[TBL] [Abstract][Full Text] [Related]
30. cT3N0 rectal cancer: potential overtreatment with preoperative chemoradiotherapy is warranted.
Guillem JG; Díaz-González JA; Minsky BD; Valentini V; Jeong SY; Rodriguez-Bigas MA; Coco C; Leon R; Hernandez-Lizoain JL; Aristu JJ; Riedel ER; Nitti D; Wong WD; Pucciarelli S
J Clin Oncol; 2008 Jan; 26(3):368-73. PubMed ID: 18202411
[TBL] [Abstract][Full Text] [Related]
31. Modified FOLFOX6 With or Without Radiation Versus Fluorouracil and Leucovorin With Radiation in Neoadjuvant Treatment of Locally Advanced Rectal Cancer: Initial Results of the Chinese FOWARC Multicenter, Open-Label, Randomized Three-Arm Phase III Trial.
Deng Y; Chi P; Lan P; Wang L; Chen W; Cui L; Chen D; Cao J; Wei H; Peng X; Huang Z; Cai G; Zhao R; Huang Z; Xu L; Zhou H; Wei Y; Zhang H; Zheng J; Huang Y; Zhou Z; Cai Y; Kang L; Huang M; Peng J; Ren D; Wang J
J Clin Oncol; 2016 Sep; 34(27):3300-7. PubMed ID: 27480145
[TBL] [Abstract][Full Text] [Related]
32. [Local recurrence and survival rate after rectal cancer operations and multimodal therapy].
Thomschke D; Kyau-Ummen B; Halbfass HJ
Chirurg; 2002 Mar; 73(3):245-54. PubMed ID: 11963499
[TBL] [Abstract][Full Text] [Related]
33. Metastatic lymph node ratio in stage III rectal carcinoma is a valuable prognostic factor even with less than 12 lymph nodes retrieved: a prospective study.
Madbouly KM; Abbas KS; Hussein AM
Am J Surg; 2014 Jun; 207(6):824-31. PubMed ID: 24112666
[TBL] [Abstract][Full Text] [Related]
34. Appropriate Timing of Surgery after Neoadjuvant ChemoRadiation Therapy for Locally Advanced Rectal Cancer.
Garrer WY; El Hossieny HA; Gad ZS; Namour AE; Abo Amer SM
Asian Pac J Cancer Prev; 2016; 17(9):4381-4389. PubMed ID: 27797248
[TBL] [Abstract][Full Text] [Related]
35. [Radiotherapy versus radiotherapy plus 5-FU in inoperable or recurrent rectal cancer].
Dunst J
Strahlenther Onkol; 1994 Apr; 170(4):245-6. PubMed ID: 8165524
[No Abstract] [Full Text] [Related]
36. [Rectal cancer: need for radiotherapy in determining the treatment plan].
Coucke PA; Bosset JF; Mirimanoff RO
Helv Chir Acta; 1991 Sep; 58(3):345-58. PubMed ID: 1769858
[TBL] [Abstract][Full Text] [Related]
37. [Analysis on efficacy and safety of total neoadjuvant therapy in patients with locally advanced rectal cancer with high risk factors].
Ouyang GL; Meng WJ; Shu P; Deng XB; Wu B; Jiang D; Zhuang H; Shen YL; Zhou ZG; Wang ZQ; Wang X
Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Apr; 22(4):349-356. PubMed ID: 31054549
[No Abstract] [Full Text] [Related]
38. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
[TBL] [Abstract][Full Text] [Related]
39. Prognostic factors in ambulatory patients with inoperable locoregionally recurrent rectal cancer following curative surgery.
Pergolizzi S; Settineri N; Santacaterina A; Maisano R; Frosina P; Loria F; Nardella G; Garufi G; Sansotta G; De Renzis C
Anticancer Res; 1999; 19(2B):1383-90. PubMed ID: 10365110
[TBL] [Abstract][Full Text] [Related]
40. Role of combined-modality therapy in the management of locally advanced rectal cancer.
Hosein PJ; Rocha-Lima CM
Clin Colorectal Cancer; 2008 Nov; 7(6):369-75. PubMed ID: 19036689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]